So sarcoma patients are unique in that sometimes there can be some difficulty in ascertaining on imaging alone, whether there is true disease recurrence. So for instance, for patients with retroperitoneal leiomyosarcoma to undergo curative intent surgery, sometimes the first imaging might find something that is concerning, but it’s unclear whether that’s purely post-surgical changes or whether that’s concerning for residual disease...
So sarcoma patients are unique in that sometimes there can be some difficulty in ascertaining on imaging alone, whether there is true disease recurrence. So for instance, for patients with retroperitoneal leiomyosarcoma to undergo curative intent surgery, sometimes the first imaging might find something that is concerning, but it’s unclear whether that’s purely post-surgical changes or whether that’s concerning for residual disease. And I have found that for positive ctDNA detection, that can really help predict and help prognosticate patients’ care and help me set up conversations for patients.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
